New Approaches

There has been so much hopeful news recently about new approaches in treating pulmonary hypertension and in some cases reversing the lung damage caused by this disease, we thought it was time to dedicate a page to the "good news".   Yes, there finally is some good news.

What you will find here is news we have collected in the PHC newsroom that we think deserves special attention.    There seems to be a lot going on in this field right now and we want to celebrate it.  One day pulmonary hypertension may be one of those diseases with a cure.   One day. 

We hope you will come here often to see what's new and what may be possible.  With so many approaches to the disease, things are looking up.

In The News

• May 21, 2013
• Hematological Effects Of Coenzyme Q Supplementation In Pulmonary Arterial Hypertension Read More: http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2013.187.1_MeetingAbstracts.A3304
• May 21, 2013
• A Focus On Stem-Cell Therapy And Regenerative Medicine For 2013
• May 15, 2013
• k-Opioid Receptor Stimulation Improves Endothelial Function in Hypoxic Pulmonary Hypertension.
• May 15, 2013
• Chlorquine restores BMPR-II in cell surfaces
• May 14, 2013
• Anticipated classes of new medications and molecular targets for pulmonary arterial hypertension.
• May 9, 2013
• Carnitine Supplement May Improve Survival Rates of Children With Heart Defects
• May 9, 2013
• The phosphodiesterase-5 inhibitor vardenafil reduces oxidative stress while reversing pulmonary arterial hypertension.
• May 9, 2013
• Reversal of pulmonary hypertension after diaphragm pacing in an adult patient with congenital central ?hypoventilation syndrome.
• April 30, 2013
• Folic acid supplementation could be important for ph-patients
• April 20, 2013
• Dehydroepiandrosterone (DHEA) Restores Right Ventricular Structure and Function in Rats with Severe Pulmonary Arterial Hypertension
• April 19, 2013
• Additive effect of phosphodiesterase inhibitors in control of pulmonary hypertension after congenital cardiac surgery in children
• April 19, 2013
• Correction of nonsense BMPR2 and SMAD9 mutations by Ataluren in Pulmonary Arterial Hypertension.
• April 14, 2013
• Treating Heart Failure Through Cardiac Regeneration
• April 13, 2013
• The Emergence of New Therapeutic Targets in Pulmonary Arterial Hypertension
• April 6, 2013
• Use of Selective Serotonin Reuptake Inhibitors and Outcomes in Pulmonary Arterial Hypertension.
• April 2, 2013
• Association of Cardiac Troponin I With Disease Severity and Outcomes in Patients With Pulmonary Hypertension.
• March 20, 2013
•  5th International Meeting on Pulmonary Rare Diseases and Orphan Drugs
• March 15, 2013
• Use of nebivolol in patients with idiopathic pulmonary hypertension: results of the pilot study
• March 15, 2013
• Inhaled PLGA Particles of Prostaglandin E1 Ameliorate Symptoms and Progression of PH at a Reduced Dosing Frequency.
• March 14, 2013
• March 12, 2013
• Tweaked protein prevents diastolic heart failure
• March 12, 2013
• Spironolactone helps left heart diastolic dysfunction patients
• February 22, 2013
• Arginase as a potential target in treatment of cardiovascular disease - Reversal of arginine steal?
• February 22, 2013
• New findings from two studies support substantial benefit of Pradaxa for prevention of recurrent deep vein thrombosis and pulmonary embolism
• February 1, 2013
• The role of vitamin D in pulmonary disease: COPD, asthma, infection, and cancer
• January 31, 2013
• Reactive oxygen species as therapeutic targets in pulmonary hypertension
• January 30, 2013
• Liposomal Fasudil, a Rho-Kinase Inhibitor, for Prolonged Pulmonary Preferential Vasodilation in Pulmonary Arterial Hypertension.
• January 30, 2013
• Emerging evidence suggests a potential critical role of mTOR signaling in pulmonary vascular remodeling.
• January 29, 2013
• New Pre-Clinical and Clinical Data on GeNO LLC's Nitric Oxide Delivery Systems to Be Presented at 2013 American College of Cardiology and American Thoracic Society Medical Meetings
• January 28, 2013
• Universiy of Giessen and Marburg, Germany starts Children-PAH-rehab study
• January 28, 2013
• Novartis withdraws application for Ruvise (Imatibib meylate) approval for PAH in EU
• January 28, 2013
• 3D contrast-enhanced lung perfusion MRI is an effective screening tool for chronic thromboembolic pulmonary hypertension
• January 10, 2013
• Synthetic Biologics to present at onemedforum San Francisco 2013
• January 10, 2013
• Elafin Granted Orphan Drug Designation for Pulmonary Arterial Hypertension
• January 9, 2013
• Enhancement of myocardial and vascular function after phosphodiesterase-5 inhibition in a rat model.
• January 8, 2013
• Silencing of STIM1 attenuates hypoxia-induced muscle cell proliferation in hypoxic lungs
• January 7, 2013
• Synthetic Biologics to Present at OneMedForum San Francisco 2013
• January 7, 2013
• Actelion to present at the 31st Annual J.P. Morgan Healthcare Conference
• December 29, 2012
• Mesenchymal stem cells attenuate vascular remodeling in monocrotaline-induced pulmonary hypertension rats.
• December 29, 2012
• Role of DHEA in cardiovascular diseases.
• December 21, 2012
• Gene silencing: Effect of small hairpin RNA targeting endothelin-converting enzyme-1 in monocrotaline-induced pulmonary hypertensive rats.
• December 20, 2012
• Therapeutic benefits of dichloroacetate. (DCA)
• December 18, 2012
• Superoxiddismutase Mimetic attenuates development of hypoxic PH and inflammation
• December 17, 2012
• Rituximab: rescue therapy in life-threatening complications or refractory autoimmune diseases: a single center experience.
• December 17, 2012
• Actelion’s macitentan NDA officially accepted
• December 5, 2012
• Pathways in pulmonary arterial hypertension: the future is here
• December 3, 2012
• Sanovas Inc. and the World Association of Bronchology and Interventional Pulmonology Launch Global Survey
• November 30, 2012
• Refined Balloon Pulmonary Angioplasty for Inoperable Patients with Chronic Thromboembolic Pulmonary Hypertension.
• November 30, 2012
• Sorafenib Is Effective in the Treatment of Pulmonary Veno-Occlusive Disease.
• November 29, 2012
• Effects of formoterol on proliferation of human pulmonary arterial vascular smooth muscle cells.
• November 27, 2012
• UCLA Performs First 'Breathing Lung' Transplant in United States
• November 27, 2012
• Unigene and Tarix Pharmaceuticals Enter Definitive Licensing Agreement for "Peptelligence-Engineered" TXA127
• November 26, 2012
• Prognostic Significance of Sympathetic Nervous System Activation in Pulmonary Arterial Hypertension
• November 16, 2012
• Patient Goes From Death Sentence to Living Life Happily With Pulmonary Hypertension Treatment
• November 15, 2012
• Attenuating Endoplasmic Reticulum Stress as a Novel Therapeutic Strategy in Pulmonary Hypertension.
• November 14, 2012
• Harvard’s Wyss Institute develops 'lung-on-a-chip’
• November 12, 2012
• VentriPoint Expands European Network of Expert Users to Include Major Cardiac Centres in Austria, Netherlands and Germany
• November 10, 2012
• Emphysema Hyperinflation Treated With Endobronchial Coils
• November 8, 2012
• Takotsubo cardiomyopathy after treatment of PAH -- lifestyle adjustement important
• November 8, 2012
• Percutaneous Transluminal Pulmonary Angioplasty for the Treatment of Chronic Thromboembolic Pulmonary Hypertension.
• November 7, 2012
• Pluristem Completes Large Scale Cell Therapy Formulation for Commercial and Clinical Trial Use
• November 6, 2012
• MAP Kinase Kinase Kinase-2 (MEKK2) regulates hypertrophic remodeling of right ventricle in hypoxia-induced pulmonary hypertension.
• October 30, 2012
• Paxillin regulates pulmonary arterial smooth muscle cell
• October 27, 2012
• Noninvasive cardiac output measurements in patients with pulmonary hypertension.
• October 27, 2012
•  Urotensin Inhibition with Palosuran Could Be a Promising Alternative in Pulmonary Arterial Hypertension.
• October 27, 2012
• Vascular endothelial cells play a larger role in pulmonary hypertension
• October 26, 2012
•  Catheder Ablation of the nerve bundle around the pulmonary artery dropped mPAP in pilot trial
• October 26, 2012
•  Propofol Increases Angiotensin-Converting Enzyme 2 Expression in Human Pulmonary Artery Endothelial Cells.
• October 23, 2012
• Pluristem Therapeutics Inc. : Pluristem Achieves Milestone Towards Completion of its New GMP Manufacturing Facility for Commercial Production of PLX Cells
• October 22, 2012
• Bayer's lung drug Riociguat shows promise in pulmonary hypertension
• October 22, 2012
• Actelion submits a New Drug Application to the FDA for macitentan (Opsumit) for the treatment of patients with PAH
• October 18, 2012
• Actelion’s Key Drug Halves Risk of Death, Hospitalization
• October 17, 2012
• Experts blaze TRAIL for pulmonary arterial hypertension therapy
• October 17, 2012
• Bayer to Present Data on Investigational Pulmonary Hypertension Compound at CHEST 2012
• October 16, 2012
•  Traditional Chinese Medicine root active component prevented PH in hypoxic rats
• October 15, 2012
• Arena Pharmaceuticals begins Phase 1 PAH trial of APD811
• October 15, 2012
•  Antibody therapy not only stopped but reversed PAH developement in animal trial
• October 7, 2012
• Plumbagin reverses proliferation and resistance to apoptosis in experimental PAH.
• October 6, 2012
• Cardiovascular Effects of Flavanol-Rich Chocolate in Patients With Heart Failure
• October 4, 2012
• Human Pentraxin 3 (PTX3) as a Novel Biomarker for the Diagnosis of Pulmonary Arterial Hypertension.
• October 3, 2012
• UA Developing Chip Monitors That Dissolve
• October 2, 2012
• Adult stem cells change their epigenome to generate new organs
• September 30, 2012
• RELAX-AHF: Positive Results With New Acute HF Treatment
• September 27, 2012
• Gene Transfer Therapy by Adeno-Associated Virus Expressing Human Prostaglandin I2 Synthase Gene is Effective for Treatment of PAH
• September 18, 2012
• ABO Blood Group Is Associated with Response to Inhaled Nitric Oxide in Neonates with Respiratory Failure.
• September 15, 2012
• HbA(1c) in pulmonary arterial hypertension: A marker of prognostic relevance?
• September 14, 2012
• Smoking history 'no bar to successful lung donation'
• September 14, 2012
• Pulmonary Arterial Hypertension in Adult-Onset Still's Disease: Rapid Response to Anakinra.
• September 12, 2012
• Novel Program Cuts CMV-Related Admissions in Transplant Patients
• September 11, 2012
• Renal denervation + PVI produces best outcomes for drug-resistant hypertension
• September 10, 2012
• Macitentan Phase III PAH outcome study results to be presented at CHEST 2012
• September 6, 2012
•  Udenafil Improves Exercise Capacity in Patients with Chronic Obstructive Pulmonary Disease: A Prospective Study.
• September 6, 2012
• Iptakalim Ameliorates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats.
• September 5, 2012
• Third Critically Ill Patient Successfully Treated With Pluristem's PLX Cells Under Compassionate Use
• September 3, 2012
• Riociguat for interstitial lung disease and pulmonary hypertension: a pilot trial.
• August 30, 2012
• Gilead's Loss in the Pulmonary Hypertension Drug Race Puts Pluristem and its Partner United Therapeutics Ahead of the Rest
• August 24, 2012
•  Riociguat vs. Sildenafil in Rats
• August 22, 2012
• The Changing Role of the Healthcare Data Center
• August 17, 2012
•  Everolimus successfully tested as treatment in 10 patients with severe PAH in a pilot trial
• August 15, 2012
•  Atorvastatin prevents pulmonary hypertension in beagles.
• August 15, 2012
• Synthetic Biologics Inc. Initiated preclinical research of Gene-Therapy for PAH
• August 14, 2012
• FDA Grants Orphan Drug Designation To GeNO LLC
• August 3, 2012
• Breathing Life Into Lung Transplants
• July 29, 2012
• Leptin levels predict survival in pulmonary arterial hypertension.
• July 29, 2012
• Modified Cardiac Stem Cells Show Promise
• July 26, 2012
•  Statins inhibit pulmonary artery smooth muscle cell proliferation
• July 26, 2012
• Policy Change Way to Go to Prevent Disease
• July 17, 2012
• Off Topic: IVIG Stops Alzheimer's in Its Tracks
• July 17, 2012
• VHVI now offers new minimally invasive, catheter-based approach to dissolve pulmonary embolism
• July 17, 2012
•  Effect of ivabradine on pulmonary hypertension in chronic obstructive pulmonary disease
• July 17, 2012
• Inhibition of Gut- and Lung-Derived Serotonin Attenuates Pulmonary Hypertension in Mice.
• July 16, 2012
• Spironolactone and Eplerenone improved PAH in 2 animal modelsof PH
• July 13, 2012
• Some types of stem cell research may be useful
• July 12, 2012
•  Protect the Heart Before a Transplant
• July 10, 2012
• Make-A-Wish Foundation makes over teenager’s bedroom
• July 8, 2012
• Pregnancy Hormone Relaxin Shows CV, Stroke Benefits
• July 6, 2012
• Exercise training in pulmonary arterial hypertension associated with connective tissue diseases
• July 5, 2012
• Safety and efficacy of exercise training in various forms of pulmonary hypertension
• July 5, 2012
• Exercise training for pulmonary hypertension: another prescription to write? By Prof. Rubin.
• July 4, 2012
• Genistein, a Soy Phytoestrogen, Reverses Severe PH and Prevents Right Heart Failure in Rats.
• July 3, 2012
• Organ Regeneration Steps Closer With "3D Sugar Printing"
• June 29, 2012
• High inter-individual variability of vardenafil pharmacokinetics in PH
• June 29, 2012
• Catheter Ablation of Typical Atrial Flutter in Severe Pulmonary Hypertension.
• June 24, 2012
• First-in-Human Transcatheter Mitral-Valve Implant
• June 22, 2012
• LEPHT study - trial locations and further details
• June 22, 2012
• Phase 2b.study: LEPHT: Left ventricular systolic dysfunction associated with pulmonary hypertension riociguat trial: rationale and design.
• June 20, 2012
• Therapeutic Potential of Valproic Acid (VPA) and Suberoylanilide Hydroxamic Acid (SAHA) in PAH
• June 15, 2012
• Combination therapy improves exercise capacity and reduces risk of clinical worsening in patients with PAH: a meta-analysis.
• June 12, 2012
• sGC stimulation totally reverses hypoxia-induced pulmonary vasoconstriction alone and combined with dual endothelin-receptor blockade in a porcine model.
• June 7, 2012
• Is Magnetic Resonance Imaging of Right Ventricular Volume Useful Clinically for Evaluation of Pulmonary Arterial Hypertension?
• June 4, 2012
• Understanding the links between inflammation and chronic disease
• May 27, 2012
• In Sight: Healthy Heart Cells from HF Patient's Skin
• May 27, 2012
• Next-Generation Transcatheter Aortic Valve Looks Good in 30-Day Registry Data
• May 27, 2012
• Mitral Device Improves HF Symptoms
• May 23, 2012
• Physical Activity Limitation as Measured by Accelerometry in Pulmonary Arterial Hypertension
• May 22, 2012
• Inhibition of PBEF is a possible therapeutic target for pulmonary hypertension
• May 21, 2012
•  Attenuation of monocrotaline-induced pulmonary arterial hypertension in rats by rosuvastatin.
• May 21, 2012
• Baseline vWF factor predicts the development of elevated pulmonary artery pressure in systemic sclerosis
• May 20, 2012
• 'Parachute' Promising for Heart Failure
• May 8, 2012
• Erectile Dysfunction Drug May Benefit Cardiac Function in Young Patients with Heart Defects
• May 5, 2012
• Actelion Gets 'Best Case' Results From Trial of PAH Drug
• May 5, 2012
• Serum osteoprotegerin (OPG) is increased and predicts survival in idiopathic pulmonary arterial hypertension.
• May 4, 2012
• Press Releases VentriPoint Launches Clinical Trial in Pulmonary Arterial Hypertension (PAH) With Top Pulmonary Hypertension Centres in the United States and Canada
• April 30, 2012
• Actelion's macitentan meets primary endpoint in pivotal Phase III SERAPHIN outcome study in patients with PAH
• April 26, 2012
• PET imaging can quantify increased cellular metabolism in pulmonary arterial hypertension
• April 18, 2012
• Stanford scientists show lab-made heart cells ideal for disease research, drug testing
• April 13, 2012
• Plumbagin reverses proliferation and resistance to apoptosis in experimental PAH.
• April 11, 2012
• New Data on GeNO LLC Nitric Oxide Delivery System to be Presented at ISHLT Conference Next Week
• April 6, 2012
• Nicorandil attenuates monocrotaline-induced vascular endothelial damage and pulmonary arterial hypertension.
• March 31, 2012
• Puerarin, an isoflavone purified from a Chinese medicine herb, promotes apoptosis..
• March 31, 2012
• Absorption, distribution, metabolism, and excretion of macitentan, a dual endothelin receptor antagonist, in humans.
• March 24, 2012
• New Approach Improves MR Detection of Pulmonary Embolism
• March 22, 2012
• FDA Clears Expanded Compatibility for INOMAX® Drug-Delivery Systems Read more here: http://www.bradenton.com/2012/03/21/3952912/fda-clears-expanded-compatibility.html#storylink=cpyThe INOMAX DS and INOMAX DSIR are proprietary drug-delivery systems that d
• March 19, 2012
• Novartis launches Arcapta(TM) Neohaler(TM), a novel once-daily bronchodilator for chronic obstructive pulmonary disease
• March 15, 2012
• UF researchers target 'traitor proteins'
• March 10, 2012
• Initial Experience With Tadalafil in Pediatric Pulmonary Arterial Hypertension.
• March 3, 2012
• Genistein attenuates monocrotaline-induced pulmonary arterial hypertension in rats
• February 27, 2012
• VentriPoint Completes Validation Study for Pulmonary Arterial Hypertension Application
• February 14, 2012
• Doctors find link between migraines, heart condition
• February 5, 2012
• Treating Pulmonary Arterial Hypertension: Current Treatments and Future Prospects
• January 20, 2012
• Studies shed new light on how nitric oxide is produced
• January 17, 2012
•  Gremlin Plays a Key Role in the Pathogenesis of Pulmonary Hypertension.
• January 6, 2012
• Heart Attack Hospital Re-Admission Rates Higher In The USA Than Abroad
• December 9, 2011
• Systemic Oxidative Stress and Endothelial Dysfunction is Associated With an Attenuated Acute Vascular Response to Inhaled Prostanoid in Pulmonary Artery Hypertension Patients.
• December 8, 2011
• Resveratrol reverses monocrotaline-induced pulmonary vascular and cardiac dysfunction
• December 7, 2011
• Epigenetic mechanisms of pulmonary hypertension.
• November 22, 2011
•  Breakthrough In Stem Cell Treatments For Heart Patients Says Cedars Sinai Hospital
• November 16, 2011
• CHEST: Oral Prostanoid Shows Promise in PAH
• November 5, 2011
• New and Emerging Anticoagulant Therapy for Atrial Fibrillation and Acute Coronary Syndrome
• November 5, 2011
• New Drug Found Effective in Phase 3 COPD Trials
• October 29, 2011
• Recent Advances in Optical Coherence Tomography for the Diagnoses of Lung Disorders
• October 29, 2011
• European Nod for HG Nerve Stimulation in Sleep Apnea
• October 29, 2011
• Treating Obstructive Sleep Apnea With Hypoglossal Nerve Stimulation
• October 26, 2011
• VIP and endothelin receptor antagonist: An effective combination against experimental PAH
• October 23, 2011
• B-type Natriuretic Peptide or Amino-terminal Pro-B-type Natriuretic Peptide-guided Treatment of Heart Failure
• October 22, 2011
• Resolving Pulmonary Embolism With Ultrasound
• October 18, 2011
• Protein could treat adult pulmonary hypertension
• October 12, 2011
• New Transplant Method May Eliminate Need for Lifelong Medication
• October 6, 2011
• Tyrosine kinase inhibitors are potent acute pulmonary vasodilators in rats.
• October 5, 2011
• Sildenafil improves the beneficial hemodynamic effects exerted by atorvastatin during acute pulmonary thromboembolism.
• October 4, 2011
• How sniffing salt could LOWER blood pressure
• September 27, 2011
• Norvartis' GTI571 (Glivec) - phase III trial IMPRES reached it's primary endpoint
• September 27, 2011
• TXA127 granted orphan drug status for PAH
• September 24, 2011
• Supercomputer Helps Predict Heart-Failure Events
• September 15, 2011
• Stem Cell Company links up with UT, makers of Remodulin
• September 13, 2011
• Novel phosphodiesterase type 5 modulators: a patent survey (2008 - 2010).
• September 11, 2011
• EU Clears Stem Cell Trial for Broken Hearts
• September 11, 2011
• DHEA inhibits the SrC/STAT3 constitutive activation in PAH
• August 31, 2011
•  Intensive Immunosuppresive Therapy Improves Long-Term-Prognosis in PAH due to Connective Tissue Disease
• August 7, 2011
• Neutrophil Elastase Regulator Needed in Systemic Sclerosis
• August 4, 2011
•  Effects of Everolimus in Combination with Sildenafil in Monocrotaline-induced Pulmonary Hypertension in Rats.
• August 1, 2011
• Transgenic expression of human matrix metalloproteinase-1 attenuated pulmonary arterial hypertension in mice
• July 27, 2011
• Efficacy and safety of once-daily aclidinium in chronic obstructive pulmonary disease
• July 26, 2011
•  Pluristem to build new Israeli stem cells facility
• July 22, 2011
• Analysis of endothelin-1 and endothelin-1 receptor A gene polymorphisms in patients with pulmonary arterial hypertension.
• July 22, 2011
• New test to identifiy no-responders in pulmonary arterial hypertension patients
• July 19, 2011
• Richard Feldman: Don't neglect the D factor
• July 15, 2011
• An endothelial progenitor cell capture chip could serve as a rapid bedside test for PAH
• July 13, 2011
• Intralipid Prevents and Rescues Fatal Pulmonary Arterial Hypertension and Right Ventricular Failure in Rats
• July 11, 2011
• Targeted gene delivery of BMPR-2 attenuates pulmonary hypertension
• July 10, 2011
• Dr. Robyn J. Barst to Lead Pulmonary Hypertension Clinical Development Program for Validation of the Ventripoint VMS(TM) Heart Analysis System
• June 20, 2011
• United Therapeutics to developnew treatment based on cells of a placenta
• June 17, 2011
• Comparison of different anticoagulants in pulmonary arterial hypertensive rats
• June 1, 2011
• Levosimendan attenuates pulmonary vascular remodeling - in animal trial
• May 30, 2011
•  Australia: Enrollment of a new trial on the effects of exercise training in PAH patients
• May 30, 2011
• NicOx presents first preclinical data in Pulmonary Arterial Hypertension research program
• May 26, 2011
•  Off topic, but quiet interesting: Sildenafil could reduce multiple sclerosis symptoms
• May 24, 2011
• Value of Impedance Cardiography in Patients Studied for Pulmonary Hypertension.
• May 10, 2011
• The Children's Hospital of Philadelphia Partners with Vascular Magnetics, Inc. to Pursue Commercial Potential of Blood Vessel Research
• April 27, 2011
• Stem Cell Transplant – Enhanced Cord Blood Stem Cell Transplants Found Safe
• April 24, 2011
• Cell Repair Therapy Improves Function in Severe Heart Failure
• April 9, 2011
• At-Home Wireless Pulmonary Artery Pressure Monitor Helps in Heart Failure
• April 4, 2011
•  Live human heart grown in lab using stem cells in potential transplant breakthrough
• April 4, 2011
• Michigan develops its first disease specific embryonic stemcell lines
• April 2, 2011
• Lung Ultrasound: A New Tool for the Cardiologist
• April 2, 2011
• Atrial Septostomy Helpful in Pulmonary Artery Hypertension
• March 21, 2011
• Stem Cell Therapy Shrinks Enlarged Hearts
• March 9, 2011
• Accord Biomaterials receives $1.3M NIH SBIR grant to develop pulmonary hypertension diagnotics
• March 9, 2011
• Combined inhibition of PDE3 and 4 regresses development of pulmonary hypertension
• March 8, 2011
• Research - Protective effects of hydrogen-rich saline
• March 1, 2011
• Study Finds Relationship Between PAH and Blood Cell Abnormalities
• February 24, 2011
• Public Health Care for All
• February 18, 2011
•  Aspirin Attenuates Pulmonary Arterial Hypertension in Rats by Reducing Plasma 5-Hydroxytryptamine Levels.
• February 16, 2011
• Role for miR-204 in human pulmonary arterial hypertension.
• February 14, 2011
• New Approach: Collagen-IV Contributes to Nitric Oxide-induced Angiogenesis of Lung Endothelial Cells
• February 12, 2011
• Researchers Recreate Cardiac Defect in a Lab Dish
• January 29, 2011
• The Role of Asymmetric Dimethylarginine and Arginine in the Failing Heart and its Vasculature
• January 22, 2011
• Scientists Find Inflammation Immune Cell Switch
• January 19, 2011
• EKOS Corporation Receives CE Mark To Treat Massive And Sub-Massive Pulmonary Embolism
• December 27, 2010
• Time-resolved magnetic resonance angiography: Evaluation of intrapulmonary circulation parameters in PAH.
• December 24, 2010
• Beta-estradiol attenuates hypoxic pulmonary hypertension by stabilizing the expression of p27kip1 in rats
• December 10, 2010
• Arena Pharmaceuticals Initiates Phase 1 Clinical Trial of APD811 for Pulmonary Arterial Hypertension
• December 8, 2010
• GeNO Gas Cylinder NITROSYL™ System Testing in PAH
• December 3, 2010
• FDA Clears GeNO LLC's Investigational New Drug
• November 27, 2010
• Phase 2 Trial Finds Therapy Effective for Specific Cystic Fibrosis Mutation
• November 24, 2010
• Transforming growth factor-beta inhibition attenuates pulmonary arterial hypertension in rats.
• November 22, 2010
• Significance of plasma NT-proBNP levels as a biomarker in the assessment of cardiac involvement and PH in patients with sarcoidosis.
• November 11, 2010
• Aires Pharmaceuticals, Inc. Completes $20M
• November 9, 2010
• Stem cell treatment for heart disease coming soon
• November 7, 2010
• Dabigatran Q&A: The Who, When, and How for Switching, Starting, and Stopping the New Oral Anticoagulant
• October 30, 2010
• Protein Shows Promise as a Therapeutic Target in Pulmonary Arterial Hypertension
• October 29, 2010
• Interleukin-6 as a potential therapeutic target for pulmonary arterial hypertension.
• October 25, 2010
• Blood Protein Warns of Pulmonary Hypertension
• October 25, 2010
• Gene Therapy Reverses Pulmonary Hypertension
• October 23, 2010
• Treatment of pediatric pulmonary hypertension with simvastatin: An observational study.
• October 20, 2010
• Stem cell research: a new age dawns in healthcare
• October 15, 2010
• NovaDel Pharma Inc. Announces Positive Data from Pilot Pharmacokinetic Study
• October 6, 2010
• Minimally-Invasive Treatment of Atrial Septal Defect
• October 4, 2010
• YM BioSciences licensee Pulmokine awarded NIH funding for PH
• October 1, 2010
• Harvard researchers creates stem cells from skin
• September 29, 2010
• BGS Global Hospitals Performs Heart Surgeries without Cutting Chest Bone
• September 27, 2010
• Growing replacement lungs may help those in need of a lung transplant to breathe easy
• September 14, 2010
• Gene Therapy Proves Effective in Treating Severe Heart Failure
• September 5, 2010
• Realities and Expectations of Pharmacogenomics and Personalized Medicine: Impact of Translating Genetic Knowledge into Clinical Practice